Transferrin-conjugated paclitaxel prodrugs for targeted cancer therapy

Novel folated Pluronic/poly(lactic acid) nanoparticles for targeted delivery of paclitaxel

(2016) Xiang Yuan Xiong et al.   RSC Advances

Surface engineered polymeric nanocarriers mediate the delivery of transferrin–methotrexate conjugates for an improved understanding of brain cancer

(2015) Atul Jain et al.   Acta Biomaterialia

Transferrin-mediated fullerenes nanoparticles as Fe 2+ -dependent drug vehicles for synergistic anti-tumor efficacy

(2015) Huijuan Zhang et al.   BIOMATERIALS

Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel

(2015) Sara A. Abouelmagd et al.   JOURNAL OF DRUG TARGETING

Improving Paclitaxel Delivery: In Vitro and In Vivo Characterization of PEGylated Polyphosphoester-Based Nanocarriers

(2015) Fuwu Zhang et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Nanodrug Delivery Systems: A Promising Technology for Detection, Diagnosis, and Treatment of Cancer

(2014) Anish Babu et al.   AAPS PHARMSCITECH

Nanomedicine I: In vitro and in vivo evaluation of paclitaxel loaded poly-(ε-caprolactone), poly (dl-lactide-co-glycolide) and poly (dl-lactic acid) matrix nanoparticles in wistar rats

(2014) Sekar VasanthaKumar et al.   EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS

Transferrin‘ activation: Bonding with transferrin receptors tunes KLRG1 function

(2014) Alexander Steinle   EUROPEAN JOURNAL OF IMMUNOLOGY

Improving the systemic drug delivery efficacy of nanoparticles using a transferrin variant for targeting

(2014) Ricky Y.T. Chiu et al.   JOURNAL OF CONTROLLED RELEASE

Apoptosis-like cell death pathways in the unicellular parasite Toxoplasma gondii following treatment with apoptosis inducers and chemotherapeutic agents: a proof-of-concept study

(2013) Ayu Dewi Ni Nyoman et al.   APOPTOSIS

Metronomic chemotherapy for cancer treatment: a decade of clinical studies

(2013) Adriana Romiti et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Radio-opaque theranostic nanoemulsions with synergistic anti-cancer activity of paclitaxel and Bcl-2 siRNA

(2013) Mi Hwa Oh et al.   RSC Advances

Structure and dynamics of drug carriers and their interaction with cellular receptors: Focus on serum transferrin

(2012) Ashley N. Luck et al.   ADVANCED DRUG DELIVERY REVIEWS

Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy

(2012) Mi Kyung Yu et al.   Theranostics

Development of Lipid-Based Nanoparticles for Enhancing the Oral Bioavailability of Paclitaxel

(2011) Deepti Pandita et al.   AAPS PHARMSCITECH

The long history of iron in the Universe and in health and disease

(2011) Alex D. Sheftel et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy

(2011) Lingling Shan et al.   BIOMATERIALS

PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy

(2011) Yuta Yoshizawa et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel

(2010) Fausto Petrelli et al.   EXPERT OPINION ON PHARMACOTHERAPY

Hydrotropic hyaluronic acid conjugates: Synthesis, characterization, and implications as a carrier of paclitaxel

(2010) Gurusamy Saravanakumar et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Chemotherapy counteracted

(2010) Urban Emmenegger et al.   NATURE